XyloCor Therapeutics, Inc. Employee Directory
Research ServicesPennsylvania, United States11-50 Employees
XyloCor Therapeutics, Inc. is a development-stage biotechnology company in the research services industry focused on developing first-in-class gene therapies for cardiovascular disease. The company is based in King of Prussia, Pennsylvania, at 411 Swedeland Road Suite 23-1080. It employs 11-50 people. In its recent history, John Tucker was appointed President and Chief Executive Officer in March 2026, and Rachel Mears joined the Board of Directors in January 2025. The company has pursued financing activities, including a Series B in January 2025 to support its cardiovascular gene therapy programs. The organization maintains a website at https://xylocor.com.